<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-22T20:09:19Z</responseDate><request verb="GetRecord" identifier="oai:uwspace.uwaterloo.ca:10012/5269" metadataPrefix="dim">https://dspacemainprd01.lib.uwaterloo.ca/server/oai/request</request><GetRecord><record><header><identifier>oai:uwspace.uwaterloo.ca:10012/5269</identifier><datestamp>2017-03-21T14:48:02Z</datestamp><setSpec>com_10012_9936</setSpec><setSpec>com_10012_1</setSpec><setSpec>col_10012_9941</setSpec><setSpec>col_10012_6</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="author" authority="dc03077f-f17a-4493-a3a0-177e71f2953e" confidence="600">Chen, Nan</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2010-06-17T14:35:39Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2010-06-17T14:35:39Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued">2010-06-17T14:35:39Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="submitted">2010-06-03</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">http://hdl.handle.net/10012/5269</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en">The kinamycin antitumor antibiotics, discovered in Japan in the early 1970s as secondary metabolites of the soil bacterium Streptomyces murayamaensis, were at first believed to be derivatives of the N-cyanobenzo[b]carbazole ring system. In 1994, studies in this laboratory revealed&#xd;
that the initial structural assignment was incorrect. The true structures of the kinamycins are based on&#xd;
a novel diazobenzo[b]fluorene ring system, a fused 6-6-5-6 carbon skeleton bearing an unusually&#xd;
stable diazo moiety along with a para-quinone and other functionalities. Additionally, this group&#xd;
revised the structure of isoprekinamycin (IPK), a metabolite from Streptomyces murayamaensis&#xd;
previously considered to be a fully aromatized diazobenzo[b]fluorene. IPK was shown to be an&#xd;
isomeric diazobenzo[a]fluorene possessing a fused 6-5-6-6 carbon skeleton and incorporating an&#xd;
ortho-quinonediazide moiety. These observations stimulated much research elsewhere in regard to the&#xd;
synthesis and biological activity of these structurally novel natural products. Among the notable&#xd;
discoveries in other groups was the isolation and characterization of the lomaiviticins, metabolites of&#xd;
the marine bacterium Micromonospora lomaivitiensis that are dimeric diazobenzo[b]fluorene&#xd;
analogues, which are even more potent than the kinamycins as anticancer and antibacterial agents.&#xd;
The present project was designed to develop new synthetic methods to improve access to the&#xd;
diazobenzo[b]fluorenes, with a focus on (1R,2R,3R,4S)-11-diazo-1,2,3,4,9-pentahydroxy-2-methyl-&#xd;
3,4-dihydro-1H-benzo[b]fluorene-5,10-(2H,11H)-dione, also called kinamycin F. The present project&#xd;
was also designed to carry out experimental and theoretical studies to gain insights into the structures&#xd;
and chemical properties of kinamycins, to better understand their biological properties and to identify&#xd;
how such properties might be optimized through specific structural alterations.&#xd;
A synthetic study was carried out on 2-methyl-1,4-naphthoquinone as a model for a possible&#xd;
biomimetic generation of the highly oxygenated D-ring of the kinamycins as found in kinamycin F.&#xd;
Epoxidation of the model quinone, followed by stereoselective reduction of both keto-carbonyl&#xd;
groups and ring opening of the epoxide with acetate as the nucleophile in a novel process involving&#xd;
tetramethylammonium triacetoxyborohydride provided (1R*,2R*,3R*,4S*)-2-methyl-1,2,3,4-&#xd;
tetrahydronaphthalene-1,2,3,4-tetraol in good yield. Comparison of the proton NMR characteristics of&#xd;
the model tetrol with those of the D-ring of kinamycins led to the conclusion that kinamycin F, unlike&#xd;
other kinamycins with some of their D-ring oxygen(s) bearing acyl groups, prefers a D-ring&#xd;
conformation in which the hydroxyl group that is nearest the diazo group is in a pseudo-equatorial&#xd;
orientation such that the C-O bond is approximately parallel with the diazo group. Ab initio molecular&#xd;
orbital calculations at the RHF 6-31G level led to the conclusion, supported by experimental&#xd;
measurements of diazo IR stretching frequencies, that the diazo group of kinamycin F has an&#xd;
enhanced diazonium ion character in this favoured conformation. This observation is of potential&#xd;
significance since the electrophilicity of the diazo group may play a role in the mode-of-action of the&#xd;
kinamycins, and since there is evidence to suggest that the other kinamycins may undergo conversion&#xd;
into kinamycin F in vivo before exerting their biological effect.&#xd;
A strategy for applying the results of the model study to the total synthesis of kinamycin F is&#xd;
disclosed. In addition, the construction of 6-hydroxy-8-methoxy-3-methyl-7,12-dioxo-7,12-&#xd;
dihydrotetraphen-4-yl methanesulfonate from readily available starting materials is described and&#xd;
suggestions as to how this compound might serve as a key intermediate in the biomimetic synthesis of&#xd;
kinamycin F are provided. A critical analysis of this synthetic strategy to the kinamycins in contrast&#xd;
with several other approaches that have been reported by other groups during the course of this thesis&#xd;
research is presented. Additionally it is pointed out that this synthetic method could provide&#xd;
(1S,2R,3R,4R)-5-diazo-1,2,3,4,8-pentahydroxy-3-methyl-1,2,3,4-tetrahydrotetraphene-6,7,12(5H)-&#xd;
trione as a key intermediate, which might well represent a novel analogue of the kinamycins with&#xd;
potentially intrinsic anticancer and antibacterial activity of its own, since this compound possesses a&#xd;
6-6-6-6 carbon skeleton containing an ortho-quinonediazide that could serve as an unique hybrid&#xd;
between the 6-6-5-6 diazobenzo[b]fluorene and the 6-5-6-6 diazobenzo[a]fluorene systems.&#xd;
A semi-synthetic method for generating kinamycin F from other natural kinamycins by applying&#xd;
a modified Zemplen deacylation condition is reported. Electrospray mass spectrometry was employed&#xd;
to identify products from interaction of kinamycin F with glutathione on a very small scale.&#xd;
Kinamycin F was found to form a covalent adduct with this thiol that is ubiquitous in mammalian&#xd;
cells. A discussion of the potential biological significance of this process as well as possible&#xd;
interactions with other biologically important thiols in specific potential target proteins is provided.&#xd;
A systematic ab initio molecular orbital analysis at the RHF 6-31 G level of the influence of&#xd;
substituents in the aromatic D-ring of isoprekinamycin was also carried out. The results have led to&#xd;
the suggestion of specific structural alterations that might be employed to fine tune the&#xd;
electrophilicity of the diazo group, which might affect the biological activity of such compounds.&#xd;
Despite the very high potency of the lomaiviticins as anticancer and antibacterial agents, progress&#xd;
towards badly needed practical drugs in these areas has been frustrated by a lack of access to adequate&#xd;
quantities of these complex secondary metabolites either through in vitro fermentation or total&#xd;
synthesis at the moment. In the hope that a prediction of the three dimensional properties of the&#xd;
lomaiviticins might inspire the design and synthesis of simpler analogues with comparable biological&#xd;
activities, a systematic ab initio molecular orbital study at the RHF 6-31G level was undertaken. In&#xd;
the end, predictions of the most likely conformations of lomaiviticins A and B were achieved and are&#xd;
provided as potential starting points for medicinal chemists to design simpler but equally potent and&#xd;
much more accessible analogues.</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso" lang="en">en</dim:field>
   <dim:field mdschema="dc" element="publisher" lang="en">University of Waterloo</dim:field>
   <dim:field mdschema="dc" element="title" lang="en">Synthesis and Chemistry of Kinamycins and Related Antibiotics</dim:field>
   <dim:field mdschema="dc" element="type" lang="en">Doctoral Thesis</dim:field>
   <dim:field mdschema="dc" element="comment" qualifier="hidden" lang="en">Please review the thesis at your earliest convenience as I would like to catch the tution refund deadline (June 18th). Thank you very much for your understanding and time.</dim:field>
   <dim:field mdschema="dc" element="pending" lang="en">false</dim:field>
   <dim:field mdschema="dc" element="subject" qualifier="program" lang="en">Chemistry</dim:field>
   <dim:field mdschema="uws-etd" element="degree" qualifier="department" lang="en">Chemistry</dim:field>
   <dim:field mdschema="uws-etd" element="degree" lang="en">Doctor of Philosophy</dim:field>
   <dim:field mdschema="uws" element="typeOfResource" lang="en">Text</dim:field>
   <dim:field mdschema="uws" element="peerReviewStatus" lang="en">Unreviewed</dim:field>
   <dim:field mdschema="uws" element="scholarLevel" lang="en">Graduate</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
</dim:dim>
</metadata></record></GetRecord></OAI-PMH>